When therapies advance from clinical development to commercial production, the stakes for data management rise sharply. Process and quality data must be validated, traceable, and ready for inspection to meet the rigorous standards of regulators like the FDA. When critical information is spread across lab systems, spreadsheets, PDFs, and even handwritten notes, it creates compliance risks, slows regulatory submissions, and limits insight into manufacturing performance.

That’s exactly the situation one mid-sized biopharma company found itself in as it scaled up production of a novel therapy. Fragmented, unvalidated systems made it difficult to ensure data integrity and readiness for FDA inspection. Manual reporting processes consumed 10 full-time employee (FTE) days each month—time that could have been better spent on science.

A Scalable, Validation-Ready Drug Manufacturing Data Warehouse

To solve these challenges, the company partnered with Clovertex to build a centralized, cloud-based data warehouse designed specifically for regulated environments. Built on Oracle Cloud Infrastructure (OCI), the platform unified structured and unstructured data, integrated lab and manufacturing systems, and applied NLP (Natural Language Processing) pipelines to extract insights from legacy PDFs and handwritten lab notes.

Key Features Included

• Unified Data Integration across LIMS, MES, and legacy documents
• NLP-Powered Analytics to unlock hidden insights from unstructured data
• Validation-Ready Processes meeting FDA 21 CFR Part 11 and cGMP standards
• Audit-Ready Dashboards for quality, manufacturing, and regulatory teams